US2003108960A1PendingUtilityA1
Antigens and immunoassays for diagnosing Chagas' disease
Est. expiryJul 30, 2018(expired)· nominal 20-yr term from priority
Inventors:Maan Zrein
G01N 33/56905A61P 33/02Y10S530/822Y10S435/975C07K 14/44Y10S530/806Y02A50/30
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Transfusion of contaminated blood has become the major route of transmission for Chagas' disease. Current screening tests are insensitive and yield conflicting results, while confirmatory assays do not exist. The present invention relates to antigens and their use for serological diagnosis of Chagas' disease. More specifically, the present invention concerns assays which are able to reliably and accurately detect the presence of antibodies to various specific antigens of Trypanosoma cruzi in a highly sensitive and specific manner.
Claims
exact text as granted — not AI-modified1 . A composition comprising at least 6 recombinant and/or synthetic peptides which bind to Trypanosoma cruzi -specific antibodies and do not bind to Leishmania-specific antibodies.
2 . A composition according to claim 1 , wherein said peptides are derived from the T. cruzi antigens chosen from the group consisting of SAPA, CRA, FRA, TcD, Tc24, Ag39 and MAP proteins.
3 . A composition according to claim 2 , wherein said peptides have amino acid sequences given by SEQ ID No 1 to 7 or any variant thereof.
4 . A method for detecting the presence of T. cruzi antibody in a biological sample, comprising:
contacting said biological sample with the peptides of the composition according to any of claims 1 to 3 , and detecting in a biological sample the presence of antibodies that bind to the peptides of the composition according to any of claims 1 to 3 .
5 . A method according to claim 4 wherein the step of detecting comprises:
removing unbound sample,
adding a detection reagent, and
determining the level of reacting antibodies relative to a predetermined cutoff value.
6 . A method according to any of claims 4 to 5 wherein said peptides of the composition according to any of claims 1 to 3 are bound to a solid support.
7 . A method according to claim 6 wherein said solid support comprises nylon, nitrocellulose, latex, dextran, gold and/or a plastic material.
8 . A method according to any of claims 6 to 7 wherein said peptides of the composition according to any of claims 1 to 3 are bound to a solid support in a line-wise fashion.
9 . A diagnostic kit for detecting T. cruzi infection in a biological sample, comprising a composition according to any of claims 1 to 3 .
10 . A diagnostic kit according to claim 9 wherein said kit further comprises a detection reagent.Join the waitlist — get patent alerts
Track US2003108960A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.